Rate and predictors of loss to follow-up in HIV care in a low-resource setting: analyzing critical risk periods

Why Do Some People Stop HIV Treatment? Understanding the Key Moments
In the global fight against HIV, keeping people engaged in their treatment is crucial. Even though many countries aim to meet ambitious HIV care goals by 2030, a significant challenge remains: helping those who start HIV treatment continue their care and keep their virus under control. A big part of this challenge is what’s known as "loss to follow-up" (LTFU).
What is Loss to Follow-Up (LTFU)?
LTFU happens when someone on HIV treatment misses their medical appointments or stops taking their medication for over 28 days. This is a serious issue, as it can lead to poorer health, increased risk of death, and a higher chance of spreading HIV to others because the virus isn’t being suppressed.
When Do People Stop Treatment?
This study looked at 737 adults who were new to HIV care and identified the times when they were most likely to stop their treatment:
- The First 6 Months Are Critical: About 50% of the people who dropped out of care did so within the first six months. This early period is a high-risk time, with an LTFU rate nine times higher than later periods (13-24 months). People might face challenges like dealing with side effects, struggling to adjust to a new routine, or not yet seeing the benefits of the medication.
- 7-12 Months: A Continued Risk: Even though the risk of dropping out decreases after the first six months, many people still struggle to stick with their treatment during months 7-12. About 30% of those who stopped care did so during this time. Factors like financial difficulties, stigma, or transportation issues can continue to affect them.
- After 12 Months: A More Stable Phase: After a year on treatment, the dropout rate drops significantly. By this time, many patients have adjusted to their routine, seen improvements in their health, and are more committed to their treatment.
What Can We Do About It?
The findings suggest that the first six months of HIV treatment are a make-or-break time. Health programs should focus on providing extra support during this period, such as helping patients manage side effects and offering counseling. Continued support is also important in the following months to help people overcome challenges that might come up later.
Follow the Topic
-
BMC Infectious Diseases
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Infectious disease and antibiotic resistance epidemiology
BMC Infectious Diseases welcomes submissions to our Collection Infectious disease and antibiotic resistance epidemiology.
Infectious disease and antibiotic resistance epidemiology are critical areas of research that intersect to address the growing threat posed by antibiotic resistant pathogens. The rise of antibiotic resistance has emerged as a global health crisis, complicating the treatment of common infections and leading to increased morbidity and mortality. Understanding the epidemiological patterns of infectious diseases, alongside the mechanisms and trends of antibiotic resistance, is essential for developing effective public health strategies. This Collection aims to explore the dynamics of infectious diseases and the implications of antibiotic resistance, providing a platform for researchers to share their findings and insights.
Advancing our understanding of infectious disease and antibiotic resistance epidemiology is vital for informing public health policies and clinical practices. Recent developments in genomic sequencing and epidemiological surveillance have enhanced the ability to track resistance patterns and identify emerging threats. Furthermore, the implementation of antibiotic stewardship programs has shown promise in mitigating the impact of antibiotic resistance. Continued research in this area will enable the development of targeted interventions, enhance patient treatment, improve infection control measures, and ultimately reduce the burden of resistant infections on healthcare systems.
This Collection seeks to enhance our understanding on infectious disease and antibiotic resistance epidemiology. By fostering interdisciplinary collaboration, we can improve the capacity to combat antibiotic resistance and safeguard public health. Key topics of interest for submission include, but are not limited to:
Epidemiological surveillance of antibiotic resistance
Mechanisms of multidrug resistance (MDR)
Antibiotic stewardship practices and outcomes
Resistance patterns in healthcare-associated infections
Genotypic and phenotypic resistance profiling
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Sep 19, 2025
Seasonal respiratory infections
BMC Infectious Diseases is calling for submissions to our Collection on Seasonal respiratory infections.
Seasonal respiratory infections, including the common cold and influenza, pose significant public health challenges, leading to substantial morbidity and mortality worldwide. Understanding the epidemiology and transmission dynamics that influence the spread of these infections is crucial for effective prevention and control strategies.
It is important for us to continue advancing our collective understanding of seasonal respiratory infections to inform evidence-based public health interventions and policies. Recent advances in this area have elucidated the complex interplay between viral dynamics and human behavior in driving the spread of respiratory infections. Additionally, research has highlighted the importance of integrated surveillance systems, early warning mechanisms, and targeted vaccination strategies in mitigating the impact of seasonal respiratory infections. Key topics of interest for submission include, but are not limited to:
-Spatio-temporal patterns of respiratory viral diseases: studies examining the geographical and temporal distribution of seasonal respiratory infections
-Epidemiological studies: research on the interaction between pathogens, hosts, and the epidemiology of respiratory infections
-Surveillance strategies: development and evaluation of surveillance systems for monitoring respiratory infections, including integrated and real-time surveillance
-Management approaches: studies on clinical management, public health interventions, and policy implications for controlling seasonal respiratory infections
-Effectiveness of vaccination campaigns: research evaluating the impact and efficacy of vaccination programs in preventing and controlling seasonal respiratory infections
-Early warning mechanisms: development and assessment of predictive models and early warning systems for anticipating outbreaks of respiratory infections
-Human behavior and transmission dynamics: analysis of how human behavior, social practices, and movement patterns affect the spread of respiratory viruses
-Healthcare system response: evaluation of healthcare system preparedness, response strategies, and resilience in the face of seasonal respiratory infections
We welcome submissions that contribute to a deeper understanding and better management of seasonal respiratory infections to protect public health globally. This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 11: Sustainable Cities and Communities.
Publishing Model: Open Access
Deadline: Apr 07, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in